In breast cancer, Gal-3 can activate Wnt signaling by mediating β-catenin nuclear localization via direct β-catenin Gal-3 interactions and enhancing Wnt target gene transcription [27,73]. This evidence concerns the gene LGALS3 and breast cancer.